Search bioRxiv⌕ Search

Biology subjects

Nir Halber, S.

Publications and source records attributed to Nir Halber, S..

2 recordsLinked to original sources

A Blueprint of Sex-Specific Neuronal Regulation in the C. elegans Nervous System at Single-Cell Resolution

Sex-specific behaviors are often attributed to differences in neuronal wiring and molecular composition, yet how genetic sex shapes the molecular architecture of the nervous system at the individual neuron level remains unclear. Here, we use single-cell RNA sequencing to profile the transcriptome of sex-shared neurons in adult Caenorhabditis elegans males and hermaphrodites. We uncover widespread molecular dimorphism across the nervous system, including in previously unrecognized neuron-types such as the touch receptors. Neuropeptides and signaling-related genes exhibit strong sex-biased expression, particularly in males, reinforcing the notion that neuropeptides are crucial for diversifying connectome outputs. Despite these differences, neurotransmitter identities remain largely conserved, indicating that functional dimorphism arises through modulatory, not identity-defining, changes. We show that sex-biased expression of neurotransmitter-related genes correlates with bias in outgoing synaptic connectivity and identify regulatory candidates for synaptic wiring, including both shared and sex-specific genes. This dataset provides a molecular framework for understanding how subtle regulatory differences tune conserved circuits to drive sex-specific behaviors.

neuroscience↗

Hormone circuit analysis explains why most HPA drugs fail for mood disorders and predicts the few that work

Elevated cortisol causes morbidity in chronic stress and mood disorders, including metabolic and cardiovascular diseases. There is therefore interest in developing drugs that lower cortisol by targeting its endocrine pathway, the hypothalamic-pituitary-adrenal (HPA) axis. Several promising HPA-modulating drugs have, however, failed to lower long-term cortisol in mood disorders such as major depressive disorder despite their effectiveness in situations where high cortisol is caused by a tumor (Cushings syndrome). Why these drugs failed is not well understood. Here we use a mathematical model of the HPA axis to show that the pituitary and the adrenal glands compensate for the effect of drugs by adjusting their functional mass, a feedback compensation that is absent in Cushing tumors. To find potential drug targets, we carried out a systematic in silico analysis of points of intervention in the HPA axis. We find that only two interventions that target corticotropin-releasing hormone (CRH) can lower long-term cortisol. Other drug targets either fail to lower cortisol due to gland-mass compensation or lower cortisol but harm other aspects of the HPA axis. Thus, we identify potential drug targets, including CRH-neutralizing antibodies and CRH-synthesis inhibitors, for lowering long-term cortisol in mood disorders and in those suffering from chronic stress. More generally, this study indicates that understanding the slow compensatory mechanisms in endocrine axes can be crucial in order to prioritize drug targets.

systems biology↗